Centiva Capital, LP Ptc Therapeutics, Inc. Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $440,485 - $573,037	-11,607 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $543,207 - $799,954	11,607 New	11,607 $550,000
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $209,057 - $294,842	-4,359 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $197,942 - $248,768	4,359 New	4,359 $204,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $391,118 - $607,799	-12,139 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$33.82 - $48.17 $410,540 - $584,735	12,139 New	12,139 $411,000

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.